Delivery Order SPE2DB20D3303-SPE2DB25FA2TU
- Not listed
- The Defense Logistics Agency awarded a $17,804.46 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Vaxneuvance 0.5 mL syringes. This is a firm fixed price, competitively awarded contract with an ultimate completion date of July 22, 2025, and will be performed in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime...
- The Defense Logistics Agency awarded a delivery order valued at $58,226.32 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes. This firm fixed-price contract, issued on July 31, 2025, represents a non-set-aside award made through open competition. The work will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $13,360.62 to AmerisourceBergen Drug Corp for Vaxneuvance 0.5 mL syringes on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under the company's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes valued at $1,370.34 on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price contract represents a non-competitive set-aside and will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes, with a ceiling value of $3,893.84. The contract, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $12,202.12 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vaxneuvance is a pneumococcal vaccine product, reflecting the ongoing federal...
- The Defense Logistics Agency awarded a $6,512.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes on August 4, 2025, with an ultimate completion date of August 5, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion and extending through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Vaxneuvance 0.5 mL syringes valued at $20,502.36. This firm fixed-price delivery order, which is set to conclude on September 11, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside designation, reflecting AmerisourceBergen's established capability to meet federal...
- The Defense Logistics Agency awarded a $7,582.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vaxneuvance 0.5 mL syringes on August 1, 2025, with an ultimate completion date of August 4, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999 global pharmaceutical support vehicle valued through December 2026. The...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at two thousand seven hundred twenty-seven dollars and twenty-four cents ($2,727.24) to Amerisourcebergen Drug Corporation for Vaxneuvance 0.5 ml syringes. The delivery order, issued under an unspecified government-wide acquisition contract, calls for four hundred fifty-six thousand two hundred eight (456,208) Vaxneuvance vaccine syringes to be delivered to a facility in Conshohocken, Pennsylvania...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2TUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,740.70 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes on August 19, 2025, with an ultimate completion date of August 20, 2025. This contract utilized firm fixed price pricing and was competitively awarded without any set-aside designation. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement valued through December 2026 that supports comprehensive pharmaceutical and medical supply needs for military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Logistics Agency's medical supply chain. The company's extensive portfolio of federal contracts demonstrates its capability to deliver a wide range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. This specific delivery order for Vaxneuvance vaccines represents one of numerous small-value transactions the contractor fulfills under its prime vendor agreement, enabling rapid response to federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/19/25 |